v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Research and development (“R&D”) expenses, net $ 3,536 $ 6,608 $ 13,049 $ 16,102
Amortization of intangible assets 380 380 1,139 1,139
General and administrative expenses 2,633 2,845 7,471 8,436
Operating loss 6,549 9,833 21,659 25,677
Other income (52)   (52)  
Interest expenses 555 172 1,504 172
Financial expenses (income), net (280) 16 (706) (96)
Loss before tax 6,772 10,021 22,405 25,753
Tax expenses 8 10 26 16
Net loss $ 6,780 $ 10,031 $ 22,431 $ 25,769
Basic and diluted loss per share of Common Stock (in Dollars per share) $ 0.23 $ 0.37 $ 0.75 $ 1.03
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares) 29,907,812 27,077,903 29,812,542 25,120,037

Source